Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Protein-Drug Binding: Determination Methods

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...

Drug-Receptor Bonds

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...

Measurement of Bioavailability: Pharmacodynamic Methods

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Wnt/β-Catenin Signaling Drives Thioacetamide-Mediated Heteroprotection Against Acetaminophen-Induced Lethal Liver Injury.

Dose-response : a publication of International Hormesis Society·2017

Same author

Hepatic Overexpression of Annexin A1 and A2 in Thioacetamide-Primed Mice Protects Them Against Acetaminophen-Induced Liver Failure and Death.

International journal of toxicology·2016

Same author

Once initiated, how does toxic tissue injury expand?

Trends in pharmacological sciences·2012

Same author

Dose-dependent liver tissue repair in chloroform plus thioacetamide acute hepatotoxicity.

Environmental toxicology and pharmacology·2011

Same author

Liver regeneration: a critical toxicodynamic response in predictive toxicology.

Environmental toxicology and pharmacology·2011

Same author

Functional characterization of peroxisome proliferator-activated receptor-β/δ expression in colon cancer.

Molecular carcinogenesis·2011

Same journal

Sperm-Binding Assay Using an In Vitro 3D Model of the Mammalian Cumulus-Oocyte Complex.

Current protocols in toxicology·2020

Same journal

Using Human Primary Foreskin Fibroblasts to Study Cellular Damage and Mitochondrial Dysfunction.

Current protocols in toxicology·2020

Same journal

An Open-Globe Porcine Injury Platform for Assessing Therapeutics and Characterizing Biological Effects.

Current protocols in toxicology·2020

Same journal

A Protocol to Study Mitochondrial Function in Human Neural Progenitors and iPSC-Derived Astrocytes.

Current protocols in toxicology·2020

Same journal

Measuring Changes in Keap1-Nrf2 Protein Complex Conformation in Individual Cells by FLIM-FRET.

Current protocols in toxicology·2020

Same journal

In Vitro Evaluation of Toxicant Influences on the Immune System.

Current protocols in toxicology·2020

See all related articles

Search research articles

Related Experiment Video

Updated: May 17, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Measuring covalent binding in hepatotoxicity.

Sachin S Devi¹, Prajakta S Palkar, Harihara M Mehendale

¹Michigan State University, East Lansing, Michigan, USA.

Current Protocols in Toxicology

|October 10, 2012

Summary

This summary is machine-generated.

Many toxic chemicals cause liver damage by forming reactive metabolites that bind to proteins. Measuring this covalent binding helps estimate liver injury and evaluate toxicant effects.

More Related Videos

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by ³²P-postlabeling

Published on: March 20, 2018

Related Experiment Videos

Last Updated: May 17, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by ³²P-postlabeling

Published on: March 20, 2018

Area of Science:

Toxicology
Biochemistry
Molecular Biology

Background:

Hepatotoxicants like acetaminophen form reactive metabolites that bind to proteins, causing liver damage.
Directly measuring unstable reactive metabolites is difficult.
Covalent binding to proteins serves as an indirect measure of reactive metabolite formation.

Purpose of the Study:

To describe methods for measuring the covalent binding of reactive metabolites to proteins.
To provide a protocol for quantifying bioactivation-based liver injury.

Main Methods:

Describes a protocol using radiolabeled compounds to measure covalent binding.
Mentions alternate methods like immunoblotting and immunohistochemistry.

Main Results:

Covalent binding measurement offers a way to estimate reactive metabolite formation.
This estimation quantifies bioactivation-based injury from hepatotoxicants.

Conclusions:

Measuring protein covalent binding is a key method for assessing hepatotoxicity.
The choice of method and timing are crucial for accurate evaluation of toxicant-induced liver injury.